Luis Dominguez-Posado
Salamanca, CL, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
ctDNA-derived copy-number signatures associated with immune checkpoint inhibitor resistance beyond PD-L1 and TMB in advanced NSCLC.
Journal: Frontiers in oncology
Published: May 08, 2026
Effects of a 12-Week Supervised Exercise Program on Quality of Life, Functional Capacity, and Biological Parameters in Women with Breast Cancer: A Prospective Pilot Program.
Journal: Journal of clinical medicine
Published: January 18, 2026
Exploratory plasma ctDNA genomic biomarkers identified by whole-exome sequencing and a novel bioinformatics pipeline in advanced driver-negative NSCLC.
Journal: Scientific reports
Published: January 17, 2026
Steroid-Refractory Cholestatic Immune-Mediated Hepatitis Following Nivolumab Therapy in an Elderly Patient with Metastatic Melanoma: A Rare and Challenging Presentation.
Journal: Current oncology (Toronto, Ont.)
Published: November 08, 2025
Pembrolizumab-Associated Hemophagocytic Lymphohistiocytosis in Clear Cell Renal Carcinoma: Case Report and Literature Review.
Journal: Reports (MDPI)
Published: October 25, 2025
Neoadjuvant chemoimmunotherapy or chemoradiotherapy in stage III non-small cell lung cancer: crossing the Rubicon?
Journal: Chinese clinical oncology
Published: May 20, 2025
Case Report: Mucoepidermoid carcinoma of the lung, a challenging diagnosis of an unusual case.
Journal: Frontiers in oncology
Published: May 11, 2025
A comprehensive review of sex differences in the clinical outcomes to immunotherapy on solid tumors.
A comprehensive review of sex differences in the clinical outcomes to immunotherapy on solid tumors.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: April 14, 2025
Prognostic impact of negative TTF-1 biomarker in metastatic lung adenocarcinoma treated with chemo-immunotherapy: a retrospective cohort study.
Journal: Translational lung cancer research
Published: January 17, 2025
Inflammatory Mesenteric Disease and Sarcoidosis-like Reaction in a Patient with Lung Adenocarcinoma Who Received Pembrolizumab: Paraneoplastic Syndrome, Secondary to Checkpoint Inhibitor or Chance Finding?
Journal: Current oncology (Toronto, Ont.)
Published: September 11, 2024
Active treatment at the end of life-importance of palliative care in advanced non-small cell lung cancer: a cohort study.
Journal: Annals of palliative medicine
Published: June 22, 2024
Last Updated: 09/26/2026